NCT00000259View on ClinicalTrials.gov

Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 1996

Primary Completion Date

November 30, 1997

Study Completion Date

November 30, 1997

Conditions
Opioid-Related DisordersSubstance-Related Disorders
Interventions
DRUG

15 % Nitrous oxide

DRUG

0.3 % Sevoflurane

DRUG

30% Nitrous oxide

DRUG

0.6% Sevoflurane

OTHER

Placebo

Trial Locations (1)

60637

University of Chicago, Anesthesia & Critical Care, Chicago

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Chicago

OTHER

NCT00000259 - Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11 | Biotech Hunter | Biotech Hunter